TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

KPJ

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

KPJ

ST13

US500000079375220

Classe

5, 10, 42

Pedido

79375220

Registro

7574734

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

32

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 42

Data de depósito

30/03/2023

Data de registro

26/11/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

26/11/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

AU

Examinador

AGREDA, SAMANTHA LEIGH

Unidade examinadora

N50

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

IISHIELD PTY LTD

Representantes

Jennifer A. Visintine Thompson Coburn LLP

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Renal scanning agents for medical use being pharmaceutical preparations for use in ex-vivo and in-vivo diagnosis of kidney disorders; renal scanning agents for medical use being pharmaceutical preparations for use in in-vivo diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic materials for medical use being pharmaceutical preparations for the diagnosis of kidney disorders; diagnostic testing materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo diagnostic materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic preparations for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; diagnostic preparations for medical use in-vivo diagnosis being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo radiodiagnostic agents for medical use being pharmaceutical preparations for use in the radiodiagnosis of kidney disorders; diagnostic scanning agents for in-vivo use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in vivo medical diagnostic scanning agents for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; pharmaceutical preparations for the preservation and storage of human organs between transplant surgeries; pharmaceutical preparations for the preservation and storage of human organs; solutions for medical use being pharmaceutical preparations for use in the preservation of organs between transplant surgeries; solutions for medical use being pharmaceutical preparations for use in the storage of organs between transplant surgeries

Classe 10

medical supports for the body, namely, a medical sheath for the encasement of donor transplant organs during storage and transportation; medical supports for the body, namely, a medical sheath for the encasement of donor transplant organs during transplantation surgery; surgical apparatus for use in transplant surgery, namely, a medical sheath for the encasement of donor transplant organs during storage and transportation; surgical implants comprised of artificial materials; medical apparatus and instruments for the purposes of long-term graft survival during organ transplant surgery; medical apparatus and instruments for the purposes of short-term graft preservation during organ transplant surgery

Classe 42

Research and development of technology in the field of maintenance, preservation, transportation and storage of organs in-vivo and ex-vivo; research and development of new products for others; scientific research to develop new products; scientific research into the development of new products; technical research into the development of new products; medical research services in relation to maintaining and improving the quality of organs in-vivo and ex-vivo; medical and pharmacological research services; medical research, namely, analysis of tissues for medical research; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research for medical purposes; pharmacological research not for medical purposes, namely, conducting pharmacological testing on organs and body parts in-vivo and ex-vivo; advisory services relating to pharmacology; consultancy pertaining to pharmacology; medical and scientific research, namely, conducting clinical trials for others; providing information about medical and scientific research in the field of pharmaceuticals, clinical trials and organ transplant surgeries; providing scientific research information and information about new product design, including online; scientific research consultancy in the field of pharmaceuticals, clinical trials and organ transplant surgeries; scientific research

Publicações

Histórico de despachos e eventos da marca no USPTO.

32 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/05/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

22/04/2025

FIMP

FINAL DISPOSITION PROCESSED

22/04/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

26/02/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

10/01/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/12/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

25/12/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

26/11/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

26/11/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

24/09/2024

PUBO

PUBLISHED FOR OPPOSITION

24/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/09/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

19/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/07/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/07/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

15/07/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/07/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/07/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

15/07/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

15/07/2024

RFNT

REFUSAL PROCESSED BY IB

06/02/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

18/01/2024

RFRR

REFUSAL PROCESSED BY MPU

18/01/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

30/12/2023

CNRT

NON-FINAL ACTION WRITTEN

29/12/2023

DOCK

ASSIGNED TO EXAMINER

26/12/2023

MAFR

APPLICATION FILING RECEIPT MAILED

15/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/08/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/08/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

27/07/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace KPJ ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.